RHEACELL

Welcome to the Brand page for “RHEACELL”, which is offered here for The mark consists of the stylized word rheacell above a design consisting of two arrowheads making an x design.;pharmaceutical and veterinary preparations for treatment of skin diseases; pharmaceutical and veterinary preparations for the treatment of vertigo; pharmaceutical and veterinary preparations for treatment of nausea; pharmaceutical and veterinary preparations for treatment of vomiting; pharmaceutical and veterinary preparations for treatment of migraine; pharmaceutical and veterinary preparations for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, the urinary system, the integumentary system, and the reproductive system; pharmaceutical and veterinary preparations for treatment of blood diseases and disorders; pharmaceutical and veterinary preparations, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; pharmaceutical and veterinary preparations for wound healing; pharmaceutical and veterinary preparations for anti-aging, stem cells for medical and aesthetic purposes, fibroblasts for medical and aesthetic purposes, surgical tissue implants obtained from stem cells, surgical tissue implants obtained from fibroblasts;color is not claimed as a feature of the mark.;the wording rheacell has no meaning in a foreign language.;medical services;scientific and technological services, medical and scientific research services in the fields of regenerative medicine and tissue engineering, scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering, consulting services relating to scientific research in the fields of regenerative medicine and tissue engineering, providing information on medical and scientific research on pharmaceutical products, providing information in the form of expert reports relating to scientific research in the fields of regenerative medicine and tissue engineering; industrial analysis, chemical analysis; research services, laboratory research services relating to pharmaceuticals, medical, biomedical and stem cell research in the field of regenerative medicine and tissue engineering, scientific and medical research and development for medical purposes in the field of regenerative medicine and tissue engineering, research and development services relating to new products for others, research in the field of biotechnology, research in the field of gene therapy, research and development in the field of immunology, research and development in the field of antibodies, research and development in the field of antibody technology, research and development in the field of bacteriology, research and development in the field of gene expression systems, research and development in the field of vaccines, pharmaceutical research and development services, research and development services in the field of biotechnology;.

Its status is currently believed to be active. Its class is unavailable. “RHEACELL” is believed to be currently owned by “RHEACELL GmbH & Co. KG”.